GNRHR and breast carcinoma: For example, GnRH-R is expressed in about 86% of prostate cancer, 80% of human endometrial and ovarian cancers, 80% of renal cancer, 50% of breast cancer, and 32–50% of pancreatic cancer cases (89, 111–114).